1. Introduction {#sec1-nutrients-08-00420}
===============

The rising prevalence of overweight and obesity has become a major global health challenge \[[@B1-nutrients-08-00420]\]. Obesity is a major risk factor for a series of metabolic disorders and chronic diseases, including insulin resistance, metabolic syndrome, type 2 diabetes, hypertension, cardiovascular diseases and certain cancer \[[@B2-nutrients-08-00420],[@B3-nutrients-08-00420],[@B4-nutrients-08-00420],[@B5-nutrients-08-00420]\]. Accumulating evidence has proved that nutritional factors are strongly associated with the development, treatment and prevention of chronic diseases, such as obesity, hyperlipidemia, diabetes mellitus and cardiovascular diseases \[[@B6-nutrients-08-00420],[@B7-nutrients-08-00420],[@B8-nutrients-08-00420],[@B9-nutrients-08-00420]\]. Therefore, it is urgent to improve etiologic research on diet by investigating nutrient and food intakes and reasonable dietary guidelines should be proposed by the government.

Histidine, a precursor for the synthesis of histamine, is abundant in red meat and fish and is an important amino acid for humans. It has been reported that lower plasma concentration of histidine is associated with protein-energy wasting, inflammation and oxidative stress in chronic kidney disease patients \[[@B10-nutrients-08-00420]\]. Previous animal studies confirmed that histidine supplementation could reduce body weight and ameliorates inflammation and oxidative stress of adipose tissue in a high-fat diet induced female obese rat model \[[@B11-nutrients-08-00420]\]. Moreover, dietary histidine also suppresses food intake and fat accumulation in rats \[[@B12-nutrients-08-00420]\]. In our previous study, we had found that serum histidine concentrations in obese women were significantly lower than those in non-obese women and had negative relationships with inflammation and oxidative stress \[[@B13-nutrients-08-00420]\]. The recovery of serum histidine concentrations through histidine supplementation could improve insulin resistance, reduce body mass index (BMI) and fat mass, and suppress inflammation and oxidative stress in obese women \[[@B14-nutrients-08-00420]\]. Only one cross-sectional study in Japanese adolescents showed a significantly negative correlation between energy intake and ratio of histidine to protein intake \[[@B15-nutrients-08-00420]\].

Although the central roles of dietary histidine for regulation of energy intake have already been established in animal and in vitro studies, to our knowledge, no study has analyzed the associations between dietary histidine and prevalence of obesity in general population. Moreover, whether chronic intake of dietary histidine is associated with insulin resistance, inflammation and oxidative stress in overweight/obese individuals is still unclear. The contribution of dietary histidine is not yet fully confirmed. Therefore, we assessed dietary histidine intakes of 2376 participants and examined relationships between dietary histidine and obesity in this population in this study. Furthermore, a subgroup study of 88 overweight/obese subjects (44 men and 44 women) was performed to explore the possible mechanism of the anti-obesity effect of histidine.

2. Materials and Methods {#sec2-nutrients-08-00420}
========================

2.1. Development and Validation of the IDQC {#sec2dot1-nutrients-08-00420}
-------------------------------------------

To investigate dietary habits accurately, many methods for dietary assessment have been used by researchers. The food frequency questionnaire (FFQ) provides us a convenient and economic method to assess the general dietary intakes in a large population \[[@B16-nutrients-08-00420]\]. However, traditional face-to-face FFQs are impossible to conduct in a large population during a short period as the face-to-face FFQs always consume much time \[[@B17-nutrients-08-00420]\]. Previously, a convenient tool named Internet-based dietary questionnaire for the Chinese (IDQC) has been designed and validated at Harbin Medical University previously by experts of nutrition, epidemiology and bio-statistics \[[@B18-nutrients-08-00420]\].

Commonly eaten foods were divided into 16 categories (i.e., grains, potatoes, legumes, vegetables, fungus, fruits, seeds and nuts, livestock, poultry, dairy, eggs, fish, snacks, sugar, condiments, and beverages). Reference images of each food item's weight/volume were created as references to assist the participants in making accurate estimation of food portions. Each participant had to choose the frequency and amount of each subtype of food groups. Finally, the questionnaire was uploaded to a secure website, which is free of access \[[@B19-nutrients-08-00420]\].

The IDQC has been validated as a convenient dietary assessment tool in our previous study \[[@B18-nutrients-08-00420]\]. Briefly, 644 recruited participants had completed the IDQC, the intakes of the food groups and nutrients in the IDQC were validated against those in the 3-day dietary records. The IDQC has been confirmed as an accurate tool for dietary assessment, because it has good consistency to results of 3-day dietary records. Therefore, the IDQC can be used for dietary assessment in large population.

2.2. Participants, Exclusive Criteria, Power Calculation and Study Design {#sec2dot2-nutrients-08-00420}
-------------------------------------------------------------------------

We randomly invited 3626 participants from the Health Examination Center of the Second Affiliated Hospital of Harbin Medical University. Of the 3626 invited participants, 2995 agreed to participate in our study, register an account and finish the IDQC. Firstly, online demographic questionnaires were completed by all participants; the details of which were provided in our previous published manuscript \[[@B20-nutrients-08-00420]\]. The exclusive criteria were as follows: (1) incomplete information on the IDQC; (2) extreme daily energy intake (\<800 kcal (3349 kJ) or \>5000 kcal (20,934 kJ) for males; \<600 kcal (2512 kJ) or \>4000 kcal (16,747 kJ) for females); (3) low BMI (BMI \< 18.5); and (4) diabetes diagnosis or being on a diet in the past 6 months. In total, 619 were excluded for the above reasons ([Figure 1](#nutrients-08-00420-f001){ref-type="fig"}).

For power calculation, considering the 9.9 cm standard deviation of waist circumference (WC) in the overall population, a sample size of 594 in each quartile will be sufficient to detect a difference of 2.4 cm between quartiles. Moreover, this sample size is also sufficient to detect a difference of 1.0 kg/m^2^ in BMI, at 99% power and 5% level of significance.

To explore possible mechanisms of the anti-obesity effect of histidine, 88 overweight/obese subjects were randomly selected by stratified sampling for subgroup study. Except for dietary histidine (% protein), body weight, BMI, WC, and drinking and smoking habits, there is no difference between included participants and excluded participants. Characteristics are presented in [Table S1](#app1-nutrients-08-00420){ref-type="app"}. An oral glucose tolerance test (OGTT) was performed and metabolic profile, status of inflammation and oxidative stress were also examined. A flow chart of the study population is shown in [Figure 1](#nutrients-08-00420-f001){ref-type="fig"}. This study was conducted according to the guidelines of the Declaration of Helsinki and all procedures involving humans were approved by the Human Research Ethics Committee of the Harbin Medical University (approval code \[2015\]006). Online informed consent was obtained from all participants.

2.3. Estimation of Dietary Nutrients Intake {#sec2dot3-nutrients-08-00420}
-------------------------------------------

After the online demographic questionnaire, all participants were asked to complete the IDQC for the past 4 months, and details of the IDQC are provided in our previous published manuscript \[[@B20-nutrients-08-00420]\]. The intake detail (frequency and amount) of each kind of food was obtained and average daily intakes of all nutrients were then calculated according to the China Food Composition Tables \[[@B21-nutrients-08-00420]\]. China Food Composition Tables is an important reference book for researchers of nutrition and public health of China. In this book, commonly eaten Chinese foods are evaluated and average nutrient contents (including energy, macro nutrients, trace elements, amino acids, and fatty acids) of these foods are measured by researchers and provided in the book. In our study, the histidine amount is total dietary source histidine (including protein, peptide and free form of histidine).

2.4. Anthropometric Measurements {#sec2dot4-nutrients-08-00420}
--------------------------------

All participants were asked to stand on an anthropometer without heavy clothing and shoes. Body weight and height were measured to the nearest 0.1 kg and 0.1 cm. For WC measurement, the same standard was applied for each individual. WC was measured using a flexible anthropometric tape on the horizontal plane between the lowest rib and the iliac crest, to the nearest 0.1 cm. Blood pressure was measured using a standard mercury sphygmomanometer. Each participant was seated comfortably for 10 min in a quiet room. Korotkoff sounds I and V were criteria for systolic blood pressure (SBP) and diastolic blood pressure (DBP), respectively. SBP and DBP were measured twice and the mean values were calculated. All anthropometric measurements were performed by standardized and trained personnel and have good reproducibility.

2.5. Definition of Overweight/Obesity and Abdominal Obesity {#sec2dot5-nutrients-08-00420}
-----------------------------------------------------------

BMI was defined as weight in kilograms divided by the square of height in meters (kg/m^2^). As this study was performed in Chinese population, the BMI cut-off points of Chinese subjects (overweight: 24.0--27.9; obesity ≥ 28.0) were used \[[@B22-nutrients-08-00420]\]. Abdominal obesity was defined as WC ≥ 85 cm in men and WC ≥ 80 cm in women, according to the 2006 Guidelines on Preservation and Control Overweight and Obesity in Chinese Adults classification \[[@B23-nutrients-08-00420]\].

2.6. Collection and Laboratory Analysis of Serum {#sec2dot6-nutrients-08-00420}
------------------------------------------------

Eighty-eight participants were instructed to fast overnight (more than 12 h) and fasting blood samples were collected in the morning. After fasting blood samples were obtained, each participant was asked to take 75 g glucose (dissolved in 200 mL of warm water), and after 2 h, postprandial blood samples were obtained. Blood samples were centrifuged at 3000 rpm for 15 min to obtain serum and serum were stored at −80 °C immediately. Fasting and 2 h-postprandial blood glucose levels were measured with a hand-held glucose monitoring system (One-Touch Ultra 2; Life Scan, Milpitas, CA, USA). Serum insulin concentration was measured by ROCHE Elecsys 2010 Chemiluminescence Immune Analyzer (Roche Diagnostics, Mannheim, Germany). Fasting and 2 h-postprandial serum triglyceride (TG,) total cholesterol (TC), high destiny lipoprotein (HDL) and low destiny protein (LDL) were determined using a ROCHE Modular P800 Automatic Biochemical Analyzer (Roche Diagnostics, Mannheim, Germany). Homeostasis model assessment of insulin resistance (HOMA-IR) index was calculated as previously described \[[@B24-nutrients-08-00420]\]. Serum tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), C-reactive protein (CRP), adiponectin and vaspin concentrations were assayed using ELISA with commercial kits (TNF-α, IL-1β, IL-6, and vaspin, catalog number CSB-E04740h, CSB-E08053h, CSB-E04638h, CSB-E09771h, Cusabio, China; CRP, catalog number BC-1119, Biocheck, USA; adiponectin, catalog number ab99968, Abcam, UK). Serum superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), malonaldehyde (MDA) were measured with enzymatic methods using commercial kits (Jiancheng Technology, Nanjing, China). Coefficients of variations (CVs) of lab measurements are presented in [Supplementary Materials](#app1-nutrients-08-00420){ref-type="app"}.

2.7. Statistical Analysis {#sec2dot7-nutrients-08-00420}
-------------------------

For descriptive statistics, means and SDs (or frequencies and percentages) were calculated across BMI categories (normal weight: BMI \< 24.0; overweight: 24.0--27.9; obese: ≥28.0) and compared using one-way analysis of variance (one-way ANOVA) or chi-square test, as appropriate. Dietary histidine of different BMI categories was further analyzed by means of analysis of covariance (ANCOVA).

Considering the high correlation between histidine and total protein intake (*r* = 0.925), and that nutrient densities can be used to reduce the likelihood of multicollinearity \[[@B25-nutrients-08-00420]\], we used histidine (percent total protein intake) in our study. Bivariate correlation analysis (without variants adjusted) and partial correlation analysis was performed to assess the association of branched-chain amino acid (BCAA) and BMI, WC, SBP and DBP (adjusting for age, dietary carbohydrate, fat, protein, cholesterol and fiber intake), fasting blood glucose (FBG), insulin, HOMA-IR, TC, TG, HDL, LDL, 2-h postprandial glucose (2 h-PG), 2 h-insulin, 2 h-TC, 2 h-TG, 2 h-HDL, 2 h-LDL, GSH-Px, SOD, MDA, TNF-α, IL-1β, IL-6, CRP, adiponectin and vaspin (adjusting for age, BMI, dietary carbohydrate, fat, protein, cholesterol and fiber intake).

To estimate the Odds ratio (OR) and 95% confidence interval (CI) of overweight/obesity and abdominal obesity between quartiles of dietary histidine, logistic regression model was used. Age, education, income, labor, exercise status, dietary carbohydrate, fat, protein, cholesterol, fiber intake and smoking habits in three models. The statistical analyses were carried out using SAS software (version 9.1; SAS Institute, Cary, NC, USA). By statistician and *p* \< 0.05 was considered statistically significant.

3. Results {#sec3-nutrients-08-00420}
==========

3.1. Descriptive Statistics {#sec3dot1-nutrients-08-00420}
---------------------------

The characteristics of participants by dietary histidine quartiles are summarized in [Table 1](#nutrients-08-00420-t001){ref-type="table"}. Compared with those in the first quartile of dietary histidine, participants of the 4th quartile were more likely to be youthful and had lower body weight, BMI, WC, and higher percentage of women. The highest prevalence of current smoking was observed in the 2nd quartile of dietary histidine. Income, education, labor and physical exercise status were also different between histidine quartiles (all *p* \< 0.05). SBP and DBP of the 4th quartile were also significantly lower than those in the 1st quartile of dietary histidine. The prevalence of overweight/obesity was 37.4% and the prevalence of abdominal obesity was 28.5% among our participants.

For dietary intake, total protein, total amino acids, total fat, cholesterol and fiber of the 3rd and 4th quartiles were significantly higher than the 1st quartile. Dietary carbohydrates of the 1st quartile was significantly higher than the 3rd and 4th quartiles. Total energy intake was also different between histidine quartiles (*p* = 0.048).

3.2. Dietary Histidine of Overweight and Obesity Participants Was Lower than Healthy Controls {#sec3dot2-nutrients-08-00420}
---------------------------------------------------------------------------------------------

We firstly performed this comparison to find the differences in dietary histidine among three BMI categories (normal weight \< 24.0, overweight 24.0--28.0, and obesity ≥ 28.0). In the overall male and female populations, dietary histidine of overweight and obese groups were all significantly lower than normal group (*p* \< 0.05 between normal and overweight group, *p* \< 0.01 between normal and obese group). Moreover, dietary histidine of obese group was significantly lower than overweight group (*p* \< 0.05). Confounding factors such as age, education, income, labor, exercise status, dietary carbohydrate, fat, protein, fiber and cholesterol intake and smoking habits were controlled in this study ([Figure 2](#nutrients-08-00420-f002){ref-type="fig"}).

3.3. Correlations between Dietary Histidine and Body Weight, BMI, WC, SBP and DBP {#sec3dot3-nutrients-08-00420}
---------------------------------------------------------------------------------

Bivariate correlation analysis and partial correlation analysis was used to examine these associations of dietary histidine with body weight, BMI, WC, SBP and DBP. Potential covariates (age, dietary carbohydrate, fat, protein, fiber and cholesterol intake) were adjusted in the partial correlation analysis. As shown in [Table 2](#nutrients-08-00420-t002){ref-type="table"}, we found negative correlations between dietary histidine and body weight, BMI, WC, SBP and DBP (*r* = −0.076, −0.129, −0.132, −0.106 and −0.092, respectively, all *p* \< 0.01). Because of higher histidine intake in males (male: 1.6 ± 0.8 g vs. female: 1.3 ± 0.6 g, *p* \< 0.01), we examined these associations in both gender, the significance was stronger in women. Furthermore, considering the higher histidine intake in normal BMI participants ([Figure 2](#nutrients-08-00420-f002){ref-type="fig"}), we examined these associations in different BMI categories. We found negative correlations between dietary histidine and BMI, WC, SBP and DBP in overweight and obese participants, but no significant correlation of dietary histidine and BMI, WC, and DBP were observed in normal BMI participants.

3.4. Higher Dietary Histidine Intake Is Associated with Lower Prevalence of Overweight/Obesity and Abdominal Obesity in Northern Chinese {#sec3dot4-nutrients-08-00420}
----------------------------------------------------------------------------------------------------------------------------------------

With adjustment for potential dietary and non-dietary cofounders (age, gender; income; education; labor; physical exercise; dietary carbohydrate, fat, protein, fiber and cholesterol intake; and smoking status), higher dietary histidine was inversely associated with prevalence of overweight/obesity and Abdominal obesity. As shown in [Table 3](#nutrients-08-00420-t003){ref-type="table"} and [Table 4](#nutrients-08-00420-t004){ref-type="table"}, compared with the 1st quartile, the multivariable-adjusted ORs of overweight/obesity for the 3rd and 4th quartile were 0.745 (0.572, 0.969) and 0.650 (0.482, 0.876), respectively (all *p* \< 0.05). After being stratified by gender, the significance still exists in the 4th quartile of men and the 2nd, 3rd and 4th quartile of women (all *p* \< 0.05). For abdominal obesity, the multivariable-adjusted ORs for the 2nd, 3rd and 4th quartile were 0.716 (0.539, 0.952), 0.809 (0.597, 0.995) and 0.754 (0.545, 0.943), respectively (all *p* \< 0.05). After being stratified by gender, the significance is stronger in women (all *p* \< 0.01) but no significant correlation was observed in men.

3.5. Correlations between Dietary Histidine and Status of Insulin Resistance, Inflammation and Oxidative Stress in Overweight/Obese Participants {#sec3dot5-nutrients-08-00420}
------------------------------------------------------------------------------------------------------------------------------------------------

Considering the stronger correlations between dietary histidine and BMI and WC in overweight/obese participants, 88 overweight/obese individuals were selected for subgroup study to explore the possible mechanism. Characteristics of subgroup study population are provided in [Table S1](#app1-nutrients-08-00420){ref-type="app"}. Overweight and obesity are always accompanied by abnormal postprandial metabolism, chronic low-grade inflammation and oxidative stress \[[@B20-nutrients-08-00420]\]. Therefore, serum biochemistry indexes and biomarkers of inflammation and oxidative stress were measured. Partial correlation analysis was used to examine these associations of dietary histidine with status of insulin resistance, inflammation and oxidative stress, independent of total energy intake. Potential covariates (age, BMI, dietary carbohydrate, fat, protein, fiber and cholesterol intake) were adjusted in the model. As shown in [Table 5](#nutrients-08-00420-t005){ref-type="table"}, higher dietary histidine is associated with lower FBG, HOMA-IR, 2 h-PG, MDA, TNF-α, IL-1β, IL-6, CRP, MDA and vaspin and higher GSH-Px, SOD and adiponectin of overweight/obese individuals of both sexes (all *p* \< 0.05).

4. Discussion {#sec4-nutrients-08-00420}
=============

This is the first Internet-based cross-sectional study to investigate associations between dietary histidine and prevalence of overweight/obesity and abdominal obesity in northern Chinese adults. We firstly reported that higher dietary histidine intake was associated with lower prevalence of overweight/obesity and abdominal obesity and lower BMI, waist circumference and blood pressure in northern Chinese population, which was firstly found using an Internet-based FFQ study. Moreover, we firstly reported that in overweight/obese individuals, higher dietary histidine is associated with lower FBG, HOMA-IR, 2 h-PG, MDA, TNF-α, IL-1β, IL-6, CRP, MDA and vaspin and higher GSH-Px, SOD and adiponectin.

In this study, we firstly found that dietary histidine is inversely associated with SBP and DBP in northern Chinese population, but no direct evidence was found to support our finding. Only one cross-sectional study reported a positive association between histidine and blood pressure in adolescents \[[@B25-nutrients-08-00420]\]. However, the relationship between obesity and hypertension is well established and the mechanisms through which obesity directly causes hypertension are still an area that requires more research \[[@B26-nutrients-08-00420]\]. The negative association between dietary histidine and blood pressure can be explained by anti-obesity effect of histidine.

Insulin resistance is the central feature of the metabolic syndrome and is considered as a critical link between obesity and many chronic diseases \[[@B27-nutrients-08-00420]\]. To effectively control these chronic diseases, the positive prevention of insulin resistance in obese individuals is extremely important. It has been reported that histidine supplementation could improve insulin resistance in obese women \[[@B14-nutrients-08-00420]\]. In the present study, we firstly found that dietary histidine is inversely associated with FBG, HOMA-IR and 2 h-PG in obese individuals, but no significant correlation between dietary histidine and fasting/postprandial insulin was found. These results indicated that dietary histidine also might improve insulin resistance in overweight and obese individuals. However, limited sample size may influence this effect and further studies are needed to confirm this association in normal weight individuals.

It has been confirmed that concentrations of pro-inflammatory cytokines such as TNF-α, IL-6 and CRP are elevated in obese subjects \[[@B28-nutrients-08-00420]\] and elevated TNF-α, IL-6 are associated with obesity related insulin resistance \[[@B29-nutrients-08-00420]\]. CRP is the most important inflammation biomarker in humans; it is elevated in status of systemic inflammation and is also related to insulin resistance and metabolic syndrome \[[@B30-nutrients-08-00420]\]. Therefore, the suppression of pro-inflammation cytokines is considered as an effective strategy for reducing the risk of obesity-related diseases. In animal models of diabetes, histidine supplementation could reduce the levels of IL-6, TNF-α and CRP \[[@B31-nutrients-08-00420]\]. Our previous studies in a high-fat diet induced female obese rat model also confirmed that histidine supplementation could ameliorate inflammation and oxidative stress of adipose tissue \[[@B11-nutrients-08-00420]\]. In an in vitro study, Son et al. \[[@B32-nutrients-08-00420]\] reported that histidine inhibited the hydrogen peroxide- (H~2~O~2~-) and TNF-α-induced IL-8 secretion at the transcriptional level in intestinal epithelial cells. In a previous study, we had found lower serum histidine concentrations in obese women than non-obese women. In obese women, serum histidine was negatively associated with inflammation and oxidative stress \[[@B13-nutrients-08-00420]\]. Histidine supplementation could improve IR, reduce BMI, fat mass and suppress inflammation and oxidative stress in obese women \[[@B14-nutrients-08-00420]\]. In the present study, we firstly found that dietary histidine was inversely associated with TNF-α, IL-1β, IL-6 and CRP, which indicated that dietary histidine also might improve inflammation in overweight and obese individuals. However, this correlation in normal weight individuals is unclear.

Adiponectin is a novel adipocytokine that has been suggested to play a role in the development of insulin resistance and atherosclerosis \[[@B33-nutrients-08-00420]\]. Circulating adiponectin levels were decreased in parallel with the development of insulin resistance in rhesus monkeys \[[@B34-nutrients-08-00420]\], which indicates that reduced plasma adiponectin levels might play a role in the progress of insulin resistance. In the present study, we also found positive correlation between dietary histidine and serum adiponectin in overweight/obese induviduals. Dietary histidine may increase secretion of adiponectin by suppressing inflammation and oxidative stress in white adipose tissue. Further studies are needed to verify this correlation in normal weight individuals.

Vaspin (visceral adipose tissue-derived serpin) was firstly found in an abdominal obesity with T2DM animal model and was shown as a new adipocytokine to influence insulin sensitivity of white adipose tissues in obese rats. Interestingly, the serum level of vaspin shows increasing trend in prediabetic stage, but decreased with the development of diabetes along with a sharp body weight loss \[[@B35-nutrients-08-00420]\]. Circulating vaspin is strongly associated with BMI and insulin sensitivity \[[@B36-nutrients-08-00420]\]. A meta-analysis also reporting vaspin levels in subjects with obesity and type 2 diabetes mellitus was higher than healthy controls \[[@B37-nutrients-08-00420]\]. In the present study, we firstly found that dietary histidine was inversely associated with serum vaspin in overweight/obese participants. However, the mechanism is unknown.

Oxidative stress is considered as one main cause of insulin resistance and many chronic diseases are characterized by excessive oxidative stress \[[@B38-nutrients-08-00420]\]. Therefore, the suppression of oxidative stress is an effective strategy for reducing the risk of obesity-related diseases. Previous study found that the concentrations of SOD in the serum and the mRNA expression of copper zinc superoxide dismutase (CuZnSOD) in the white adipose tissue were increased and the concentrations of MDA in the serum were decreased by histidine supplementation in high-fat diet-induced female obese rat model \[[@B11-nutrients-08-00420]\]. In the present study, we quantified three oxidative biomarkers, GSH-Px, SOD and MDA, and the results revealed that the concentrations of GSH-Px and SOD in the serum was positively associated with dietary histidine and the concentrations MDA in the serum was inversely associated with dietary histidine, which provides more evidence that histidine is a potential antioxidant in obese individuals.

For the gender and BMI difference of histidine in our study, we found that negative correlations between dietary histidine and BMI and WC were stronger in overweight and obese participants. Moreover, the association between dietary histidine and overweight/obesity and abdominal obesity is much stronger in women. Several potential mechanisms might account for this finding. In this study, lower histidine intake was observed in female participants and overweight/obese individuals, which may lead to lower serum histidine and stronger response to dietary histidine. Moreover, previous studies found that women were more sensitive to dietary histidine and energy intake than men \[[@B15-nutrients-08-00420],[@B39-nutrients-08-00420]\], but the mechanisms are still unclear and further studies are needed.

The primary limitation of this study is the cross-sectional and retrospective design. We must acknowledge that reverse causality may be exists as cross-sectional studies were insufficient to confirm the causal relationship between dietary factors and occurrence of disease \[[@B17-nutrients-08-00420]\]. Long term cohort studies for this issue are needed to verify the casual relationship; Secondly, current study was only performed in a northern Chinese population. Consider of the large population and vast territory of China, we must be rigorous when extrapolating this result to the general population. Moreover, beneficial effects of dietary histidine such as lower fasting blood glucose, insulin resistance, inflammation and oxidative stress may be associated with histidine peptides (carnosine, anserine and balenine), which has been shown in recent studies of carnosine supplementation in animals \[[@B40-nutrients-08-00420]\] and more recently in humans \[[@B41-nutrients-08-00420]\]. However, in our study, data of dietary histidine peptides were lacking. In spite of these limitations, this study provides a lot of practical significance, especially in nutritional counseling. As nutrition is important for prevention of obesity and reduction of excess body weight, reasonable dietary intervention should be useful for the prevention of overweight/obesity. For overweight/obese clients, advice of consuming more histidine-rich foods may be useful for weight control.

5. Conclusions {#sec5-nutrients-08-00420}
==============

In summary, our study adds evidence supporting the inverse associations between dietary histidine and obesity, possibly through reduction of energy intake and improvements of insulin resistance, inflammation and oxidative stress. To confirm the casual associations, long-term cohort studies of this issue are needed.
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![Dietary histidine of different body mass index (BMI) categories: (**A**) the overall population; (**B**) male participants; and (**C**) female participants. Confounding factors such as age, labor, exercise status, dietary carbohydrate, fat, protein, fiber and cholesterol intake and smoking habits were controlled.](nutrients-08-00420-g002){#nutrients-08-00420-f002}

nutrients-08-00420-t001_Table 1

###### 

Characteristics and dietary intake of participants by quartile of histidine intake.

                                      Quartiles of Histidine (% Total Protein Intake)   *p*                                                
  ----------------------------------- ------------------------------------------------- ---------------- ---------------- ---------------- ---------
  Histidine, % total protein intake   \<1.38                                            1.38--1.59       1.59--1.77       \>1.77           
  Participants, *n*                   594                                               594              594              594              
  BMI categories                                                                                                                           \<0.001
   \<24.0, *n* (%)                    327 (55.1)                                        352 (59.3)       384 (64.6)       424 (71.4)       
   24.0--28.0, *n* (%)                191 (32.2)                                        182 (30.6)       165 (27.8)       141 (23.7)       
   ≥28.0, *n* (%)                     76 (12.8)                                         60 (10.1)        45 (7.6)         29 (4.9)         
  Abdominal obesity                                                                                                                        0.020
   Yes, *n* (%)                       191 (32.1)                                        174 (29.3)       168 (28.3)       143 (24.1)       
   No, *n* (%)                        403 (67.9)                                        420 (70.7)       426 (71.7)       451 (75.9)       
  Age, year                           34.7 ± 14.9                                       34.6 ± 16.3      33.3 ± 15.5      29.9 ± 14.5      \<0.001
  Gender                                                                                                                                   0.018
   Men, *n* (%)                       319 (53.7)                                        296 (49.8)       266 (44.8)       283 (47.6)       
   Women, *n* (%)                     275 (46.3)                                        298 (50.2)       328 (55.2)       311 (52.4)       
  Body weight, kg                     67.6 ± 12.5                                       66.1 ± 11.6      65.4 ± 11.3      64.2 ± 11.4      \<0.001
  BMI, kg/m^2^                        23.8 ± 3.7                                        23.3 ± 3.3       23.2 ± 3.3       22.8 ± 3.1       \<0.001
  WC, cm                              80.6 ± 10.3                                       79.2 ± 9.7       79.0 ± 9.5       78.2 ± 9.8       \<0.001
  Income per month                                                                                                                         \<0.001
   \<2000 yuan, *n* (%)               355 (59.8)                                        366 (61.6)       374 (63.0)       442 (74.4)       
   2000--5000 yuan, *n* (%)           223 (37.5)                                        207 (34.8)       203 (34.2)       123 (20.7)       
   ≥5000 yuan, *n* (%)                16 (2.7)                                          21 (3.5)         17 (2.9)         29 (4.9)         
  Education                                                                                                                                0.021
   Under college, *n* (%)             175 (29.5)                                        145 (24.4)       132 (22.2)       122 (20.5)       
   Bachelor, *n* (%)                  398 (67.0)                                        424 (71.4)       437 (73.6)       449 (75.6)       
   Master or doctor, *n* (%)          21 (3.5)                                          25 (4.2)         25 (4.2)         23 (3.9)         
  Labor                                                                                                                                    \<0.001
   Light, *n* (%)                     164 (27.6)                                        179 (30.1)       149 (25.1)       135 (22.7)       
   Medium, *n* (%)                    391 (65.8)                                        397 (66.8)       430 (72.4)       453 (76.3)       
   Heavy, *n* (%)                     39 (6.6)                                          18 (3.0)         15 (2.5)         6 (1.0)          
  Exercise                                                                                                                                 \<0.001
   \<10 h/week, *n* (%)               281 (47.3)                                        223 (3.8)        182 (30.6)       137 (23.1)       
   10--20 h/week, *n* (%)             300 (50.5)                                        315 (53.0)       317 (53.4)       334 (56.2)       
   ≥20 h/week, *n* (%)                13 (2.2)                                          56 (9.4)         95 (16.0)        123 (20.7)       
  Smoking                                                                                                                                  0.046
   Non-smoker, *n* (%)                493 (83.0)                                        494 (83.2)       530 (89.2)       507 (85.4)       
   Current smoker, *n* (%)            73 (12.3)                                         75 (12.6)        49 (8.2)         61 (10.3)        
  Quit smoking, *n* (%)               28 (4.7)                                          25 (4.2)         15 (2.5)         26 (4.4)         
  Drinking                                                                                                                                 0.44
  Non-drinker, *n* (%)                475 (80.0)                                        489 (82.3)       495 (83.7)       480 (80.8)       
  Current drinker, *n* (%)            119 (20.0)                                        105 (17.7)       99 (16.7)        114 (19.2)       
  SBP (mmHg)                          119.1 ± 12.9                                      119.0 ± 14.1     117.7 ± 12.4     115.1 ± 11.4     \<0.001
  DBP (mmHg)                          78.9 ± 8.7                                        78.7 ± 9.1       77.9 ± 8.9       76.2 ± 8.4       \<0.001
  Dietary intakes                                                                                                                          
   Energy, kcal/day                   2448.4 ± 824.5                                    2534.2 ± 867.6   2430.5 ± 865.5   2399.9 ± 896.0   0.048
   Total protein, g/day               79.7 ± 30.5                                       92.7 ± 35.2      93.8 ± 37.9      95.0 ± 41.7      \<0.001
   Total amino acids, g/day           36.9 ± 16.8                                       54.2 ± 20.7      61.3 ± 24.7      69.8 ± 30.5      \<0.001
   Histidine, g/day                   0.9 ± 0.4                                         1.4 ± 0.5        1.6 ± 0.6        1.8 ± 0.8        \<0.001
   Total fat, g/day                   60.8 ± 28.2                                       78.5 ± 35.3      83.4 ± 37.6      81.2 ± 43.0      \<0.001
   Total carbohydrate, g/day          406.9 ± 146.3                                     382.5 ± 137.9    345.2 ± 133.4    341.9 ± 141.9    \<0.001
   Cholesterol, mg/day                405.7 ± 309.9                                     495.8 ± 338.9    489.6 ± 309.6    435.8 ± 349.0    \<0.001
   Fiber, g/day                       15.7 ± 7.6                                        20.9 ± 10.6      21.7 ± 11.1      22.6 ± 13.0      \<0.001

Abbreviations: BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; *p* are for differences across quartiles of histidine intake. Data are expressed as mean ± SD or frequencies and percentages, as appropriate.
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###### 

Correlations between dietary histidine and energy intake, body weight, BMI, WC and blood pressure.

                   Unadjusted   Adjusted \*            Unadjusted   Adjusted \*                                  
  ---------------- ------------ ------------- -------- ------------ ---------------- -------- --------- -------- ---------
  Overall                                                           Normal BMI                                   
   Energy intake   −0.031       NS            −0.053   \<0.05        Energy intake   −0.032   NS        −0.027   NS
   Body weight     −0.093       \<0.001       −0.076   \<0.01        Body weight     −0.042   NS        −0.029   NS
   BMI             −0.126       \<0.001       −0.129   \<0.001       BMI             −0.046   NS        −0.037   NS
   WC              −0.127       \<0.001       −0.132   \<0.001       WC              −0.061   NS        −0.071   NS
   SBP             −0.119       \<0.001       −0.106   \<0.001       SBP             −0.109   \<0.001   −0.056   \<0.05
   DBP             −0.104       \<0.001       −0.092   \<0.001       DBP             −0.079   \<0.01    −0.052   NS
  Men                                                               Overweight                                   
   Energy intake   −0.022       NS            −0.034   NS            Energy intake   −0.055   NS        −0.058   NS
   Body weight     −0.061       \<0.05        −0.064   \<0.05        Body weight     −0.094   NS        −0.042   NS
   BMI             −0.102       \<0.01        −0.095   \<0.05        BMI             −0.137   \<0.001   −0.133   \<0.001
   WC              −0.096       \<0.05        −0.093   \<0.05        WC              −0.114   \<0.05    −0.125   \<0.05
   SBP             −0.143       \<0.001       −0.076   \<0.05        SBP             −0.104   \<0.01    −0.097   \<0.05
   DBP             −0.112       \<0.001       −0.086   \<0.01        DBP             −0.112   \<0.01    −0.092   \<0.05
  Women                                                             Obesity                                      
   Energy intake   −0.065       \<0.05        −0.056   \<0.05        Energy intake   −0.068   \<0.05    −0.073   \<0.05
   Body weight     −0.096       \<0.05        −0.088   \<0.01        Body weight     −0.119   \<0.05    −0.104   \<0.05
   BMI             −0.136       \<0.001       −0.147   \<0.001       BMI             −0.131   \<0.01    −0.147   \<0.001
   WC              −0.138       \<0.01        −0.153   \<0.001       WC              −0.143   \<0.01    −0.142   \<0.01
   SBP             −0.066       \<0.05        0.113    \<0.01        SBP             −0.117   \<0.01    −0.113   \<0.05
   DBP             −0.065       \<0.05        −0.109   \<0.01        DBP             −0.143   \<0.05    −0.131   \<0.05

Abbreviations: BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; NS, no significance. \* Adjusting for dietary carbohydrate, fat, protein, fiber and cholesterol intake.
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###### 

Multivariable-adjusted Odds ratio (OR) and 95% confidence interval (CI) of overweight/obesity by quartile of dietary histidine.

  All                                                                                                      
  ------------------------------- ---------------- --------------------------- --------------------------- ---------------------------
  Dietary histidine (% protein)   \<1.38           1.38--1.59                  1.59--1.77                  \>1.77
  Participants, *n*               594              594                         594                         594
  Overweight/obesity, *n* (%)     267 (44.9)       242 (40.7)                  210 (35.4)                  170 (28.6)
  Crude                           1                0.768 (0.610, 0.968) \*     0.736 (0.584, 0.928) \*     0.537 (0.423, 0.681) \*\*
  Model 1                         1                0.772 (0.602, 0.990) \*     0.752 (0.586, 0.966) \*     0.646 (0.500, 0.834) \*\*
  Model 2                         1                0.777 (0.587, 1.029)        0.744 (0.572, 0.968) \*     0.649 (0.481, 0.875) \*\*
  Model 3                         1                0.772 (0.583, 1.023)        0.745 (0.572, 0.969) \*     0.650 (0.482, 0.876) \*\*
  **Men**                                                                                                  
  **Histidine Quartiles**         **Quartile 1**   **Quartile 2**              **Quartile 3**              **Quartile 4**
  Dietary histidine (% protein)   \<1.35           1.35--1.57                  1.57--1.76                  \>1.76
  Participants, *n*               291              291                         291                         291
  Overweight/obesity, *n* (%)     132 (45.4)       117 (40.2)                  98 (33.7)                   85 (29.2)
  Crude                           1                0.926 (0.671, 1.278)        0.826 (0.592, 1.154)        0.608 (0.434, 0.853) \*\*
  Model 1                         1                0.919 (0.655, 1.289)        0.843 (0.594, 1.197)        0.599 (0.490, 0.998) \*
  Model 2                         1                0.973 (0.676, 1.388)        0.828 (0.561, 1.288)        0.578 (0.468, 0.991) \*
  Model 3                         1                0.969 (0.672, 1.396)        0.838 (0.577, 1.302)        0.575 (0.456, 0.988) \*
  **Women**                                                                                                
  **Histidine Quartiles**         **Quartile 1**   **Quartile 2**              **Quartile 3**              **Quartile 4**
  Dietary histidine (% protein)   \<1.40           1.40--1.61                  1.61--1.77                  \>1.77
  Participants, *n*               303              303                         303                         303
  Overweight/obesity, *n* (%)     135 (44.6)       125 (41.3)                  112 (37.0)                  85 (28.1)
  Crude                           1                0.639 (0.461, 0.884) \*\*   0.624 (0.448, 0.871) \*\*   0.463 (0.330, 0.649) \*\*
  Model 1                         1                0.642 (0.445, 0.925) \*     0.574 (0.393, 0.837) \*\*   0.549 (0.376, 0.803) \*\*
  Model 2                         1                0.607 (0.403, 0.915) \*     0.557 (0.375, 0.827) \*\*   0.515 (0.333, 0.796) \*\*
  Model 3                         1                0.612 (0.406, 0.923) \*     0.556 (0.374, 0.826) \*\*   0.518 (0.335, 0.801) \*\*

Model 1: adjusting for age, education, income, labor and exercise status. Model 2: Model 1 + dietary carbohydrate, fat, protein, fiber and cholesterol intake were adjusted. Model 3: Model 2 + smoking habits were adjusted. \* *p* \< 0.05; \*\* *p* \< 0.01 compared with the 1st quartile.
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###### 

Multivariable-adjusted Odds ratio (OR) and 95% confidence interval (CI) of abdominal obesity by quartile of dietary histidine.

  All                                                                                                      
  ------------------------------- ---------------- --------------------------- --------------------------- ---------------------------
  Dietary histidine (% protein)   \<1.38           1.38--1.59                  1.59--1.77                  \>1.77
  Participants, *n*               594              594                         594                         594
  Abdominal obesity, *n* (%)      191 (32.1)       174 (29.3)                  168 (28.3)                  143 (24.1)
  Crude                           1                0.771 (0.603, 0.987) \*     0.752 (0.587, 0.963) \*     0.614 (0.477, 0.792) \*\*
  Model 1                         1                0.733 (0.563, 0.956) \*     0.774 (0.594, 0.996) \*     0.742 (0.565, 0.974) \*
  Model 2                         1                0.723 (0.545, 0.059) \*     0.782 (0.579, 0.998) \*     0.761 (0.552, 0.985) \*
  Model 3                         1                0.716 (0.539, 0.952) \*     0.809 (0.597, 0.995) \*     0.754 (0.545, 0.943) \*
  **Men**                                                                                                  
  **Histidine Quartiles**         **Quartile 1**   **Quartile 2**              **Quartile 3**              **Quartile 4**
  Dietary histidine (% protein)   \<1.35           1.35--1.57                  1.57--1.76                  \>1.76
  Participants, *n*               291              291                         291                         291
  Abdominal obesity, *n* (%)      120 (41.2)       118 (40.5)                  114 (39.2)                  102 (35.1)
  Crude                           1                0.972 (0.698, 1.353)        0.918 (0.659, 1.279)        0.769 (0.550, 1.075)
  Model 1                         1                0.943 (0.663, 1.341)        0.923 (0.648, 1.315)        0.908 (0.634, 1.301)
  Model 2                         1                0.948 (0.650, 1.383)        0.940 (0.627, 1.410)        0.928 (0.600, 1.435)
  Model 3                         1                0.929 (0.636, 1.357)        0.959 (0.639, 1.441)        0.916 (0.592, 1.419)
  **Women**                                                                                                
  **Histidine Quartiles**         **Quartile 1**   **Quartile 2**              **Quartile 3**              **Quartile 4**
  Dietary histidine (% protein)   \<1.40           1.40--1.61                  1.61--1.77                  \>1.77
  Participants, *n*               303              303                         303                         303
  Abdominal obesity, *n* (%)      71 (23.4)        56 (18.5)                   54 (17.8)                   41 (13.5)
  Crude                           1                0.639 (0.461, 0.884) \*\*   0.624 (0.448, 0.871) \*\*   0.463 (0.330, 0.649) \*\*
  Model 1                         1                0.499 (0.313, 0.794) \*\*   0.539 (0.280, 0.938) \*     0.507 (0.314, 0.816) \*\*
  Model 2                         1                0.477 (0.293, 0.777) \*\*   0.476 (0.278, 0.802) \*\*   0.472 (0.272, 0.821) \*\*
  Model 3                         1                0.478 (0.294, 0.778) \*\*   0.501 (0.320, 0.840) \*\*   0.473 (0.272, 0.822) \*\*

Model 1: adjusting for age, education, income, labor and exercise status. Model 2: Model 1 + dietary carbohydrate, fat, protein, fiber and cholesterol intake were adjusted. Model 3: Model 2 + smoking habits were adjusted. \*: *p* \< 0.05; \*\*: *p* \< 0.01 compared with the 1st quartile.
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###### 

Associations between dietary histidine and metabolic profile, inflammation and oxidative stress in overweight/obese participants.

                Overall   Men      Women                      
  ------------- --------- -------- -------- -------- -------- --------
  FBG           −0.179    \<0.05   −0.171   \<0.05   −0.214   \<0.05
  Insulin       −0.122    NS       −0.111   NS       −0.098   NS
  HOMA-IR       −0.233    \<0.05   −0.221   \<0.05   −0.237   \<0.05
  TC            −0.103    NS       −0.089   NS       −0.109   NS
  TG            −0.122    NS       −0.106   NS       −0.127   NS
  HDL           0.074     NS       0.033    NS       0.098    NS
  LDL           0.081     NS       0.089    NS       0.076    NS
  2 h-PG        −0.171    \<0.05   −0.167   NS       −0.189   \<0.05
  2 h-Insulin   −0.112    NS       −0.078   NS       −0.131   NS
  2 h-TC        −0.081    NS       −0.065   NS       −0.057   NS
  2 h-TG        −0.056    NS       −0.034   NS       −0.078   NS
  2 h-HDL       0.098     NS       0.035    NS       0.101    NS
  2 h-LDL       0.035     NS       0.008    NS       0.041    NS
  GSH-Px        0.265     \<0.05   0.231    \<0.05   0.283    \<0.05
  SOD           0.167     \<0.05   0.149    NS       0.198    \<0.05
  MDA           −0.202    \<0.05   −0.187   \<0.05   −0.231   \<0.05
  TNF-α         −0.271    \<0.05   −0.265   \<0.05   −0.273   \<0.05
  IL-1β         −0.178    \<0.05   −0.172   \<0.05   −0.189   \<0.05
  IL-6          −0.182    \<0.05   −0.166   \<0.05   −0.198   \<0.05
  CRP           −0.242    \<0.05   −0.178   \<0.05   −0.267   \<0.05
  Adiponectin   0.188     \<0.05   0.176    \<0.05   0.195    \<0.05
  Vaspin        −0.217    \<0.05   −0.231   \<0.05   −0.203   \<0.05

Abbreviations: FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; TG, triglyceride; HDL, high destiny lipoprotein; LDL, low destiny lipoprotein; 2 h-PG, 2 h-postprandial glucose; GSH-Px, glutathione peroxidase; SOD, superoxide dismutase; MDA, malonaldehyde; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; IL-6, interleukin-6; CRP, C-reactive protein; NS, no significance. \* Adjusting for dietary carbohydrate, fat, protein, fiber and cholesterol intake.

[^1]: These authors contributed equally to this work.
